Pacemaker for slow heart rhythm restores life expectancy

September 2, 2013

Pacemakers implanted for slow heart rhythm restore life expectancy to normal levels, reveals research presented at ESC Congress 2013 today by Dr Erik O. Udo from the Netherlands. The findings provide a new reference point for the prognosis of modern pacemaker patients.

Dr Udo said: "Previous studies describing the survival of patients used data that is more than 20 years old and cannot be used anymore for patient counselling and benchmarking. There have been considerable changes in pacemaker technology and in the profile of pacemaker patients and a new reference point of prognosis in modern day was needed."

FollowPace was a nationwide multicentre in 23 Dutch hospitals. It included 1,517 patients who received their first pacemaker for bradycardia (slow or ) between 2003 and 2007. Patients were followed for an average of 5.8 years.

The researchers found of 93%, 81%, 69% and 61% after 1, 3, 5 and 7 years respectively. Patients without cardiovascular disease (such as heart failure or ) at the time of pacemaker implantation had a survival rate similar to age and sex matched controls from the general Dutch population (see figure 1).

Dr Udo said: "Our results suggest that the prognosis of today's pacemaker patient is primarily determined by whether or not they also have cardiovascular disease, and not by the rhythm disorder itself. Patients who have heart failure or coronary artery disease when the pacemaker is implanted have the highest risk of death. On the other hand, patients without at the time of implantation have the best survival, which is comparable to the survival of the general population."

He added: "In earlier studies we showed that in cases of too slow heart rhythm, permanent pacing relieves symptoms and improves quality of life and therefore a pacemaker is the appropriate device. In this study we could document that other cardiovascular problems, such as coronary artery disease or , determine the prognosis of pacemaker patients rather than the slow heart rhythm itself."

He continued: "After pacemaker implantation for a too slow heart rhythm, more attention should be paid to the detection and treatment of other cardiovascular problems. Thus, next to the regular technical follow-ups of the pacemaker, the cardiologist should also regularly check the pacemaker recipient to improve the prognosis by treating potentially diagnosed cardiovascular diseases."

Dr Udo concluded: "The FollowPace study provides detailed documentation of current standard pacemaker care in a large representative sample of western pacemaker clinics. The results can therefore be considered a new benchmark of life expectancy of patients treated with today's cardiac pacing."

Explore further: Wireless pacemaker shows promise in early study

Related Stories

Wireless pacemaker shows promise in early study

May 9, 2013
(HealthDay)—Scientists report positive results in early testing of a wireless pacemaker that's placed in the heart instead of being connected to it via wires from the upper chest.

Team discovers an unknown channel in the heart could illuminate unsolved cases of arrhythmia

June 11, 2013
The heart's regular rhythm is crucial to the delivery of oxygenated blood and nutrients to all the organs of the body. It is regulated by a bundle of cells called "the pacemaker," which use electrical signals to set the pace ...

Pacemaker could help more heart failure patients

October 5, 2012
(Medical Xpress)—A new study from Karolinska Institutet demonstrates that a change in the ECG wave called the QRS prolongation is associated with a higher rate of heart-failure mortality. According to the team that carried ...

Pacemaker prevents fainting among select patient population

March 26, 2012
A select number of patients who suffer from neurally mediated synope (NMS) – a disorder in which the brain fails to regulate heart rate and blood pressure – may be good candidates to receive a dual-chamber pacemaker ...

Ordinary heart cells become 'biological pacemakers' with injection of a single gene

December 16, 2012
Cedars-Sinai Heart Institute researchers have reprogrammed ordinary heart cells to become exact replicas of highly specialized pacemaker cells by injecting a single gene (Tbx18)–a major step forward in the decade-long search ...

Study finds possible link between diabetes and increased risk of heart attack death

February 15, 2013
Having diabetes doubles a person's risk of dying after a heart attack, but the reason for the increased risk is not clear. A new University of Iowa study suggests the link may lie in the over-activation of an important heart ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.